Study to Evaluate the Effects of Oral Contraceptive on Hemostatic Parameters in Healthy Women

Study Title
A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women
Teva Identifier
PSE-HSP-203 | 2010-023215-34
ClinicalTrials.gov Identifier
NCT01252186
Study Status
Completed
Trial Condition(s)
Hemostasis | Oral Contraceptive
Interventions
Drug: 91-day Levonorgestrel Oral Contraceptive | Drug: 28-day Levonorgestrel Oral Contraceptive | Drug: 28-day Desogestrel Oral Contraceptive

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Participation criteria and map of study locations


Key Participation Requirements

Gender
Female
Age group
Adult
Age Range
18 Years to 40 Years
Trial Duration
11/01/2010 - 12/01/2011
Phase
Phase 2

Study Type

Interventional